Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Based in Bangkok, The Mahidol Oxford Tropical Medicine Research Unit (MORU) is a research collaboration established in 1979 between our host, Mahidol University, University of Oxford and the Wellcome Trust. We seek to seek to address health problems afflicting urban and rural populations across the tropics.

A key focus of MORU is building scientific research capacity in Thailand and SE and South Asia. One way we do this is by hosting students in a world-class research environment.

MORU currently hosts DPhil PhD and MSc students from Mahidol's Faculty of Tropical Medicine, the Nuffield Dept of Medicine at Oxford and the UK's Open University. We welcome inquiries and applications from students around the world.

We offer students opportunities in multi-disciplinary research areas such as malaria, microbiology, pharmacology, mathematical & economic modelling, epidemiology, bioethics and community engagement.

In this video, you'll hear from some of our current students about why living and studying in SE Asia and at MORU is such a great experience.

Interested? Have a look at our list of researchers for a potential supervisor and contact them directly. Or contact Professor Stuart Blacksell, Post-Graduate Student Coordinator.

MORU

The MORU Tropical Health Network has departments, labs and administrative offices in Bangkok, units in north-western Thailand, Myanmar, Cambodia, Laos and DR Congo, and collaborative study sites across Thailand and SE Asia, and in Bangladesh and India.

Research at MORU

MORU's current research focuses on malaria, melioi­dosis, scrub and murine typhus, the causes and treatment of fever and sepsis, CNS infections, critical care medicine, maternal and neonatal health, childhood pneumonia, and TB. We have a longstanding interest in medicine quality and in antimicrobial drug resistance, a major threat to the region and, in the case of artemisinin resistant falciparum malaria, to the rest of the tropical world.